These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice. Mohamed AH; Osman GY; Salem TA; Elmalawany AM Exp Parasitol; 2014 Oct; 145():7-13. PubMed ID: 25016189 [TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice. El-Agamy DS; Shebl AM; Said SA Inflammopharmacology; 2011 Dec; 19(6):307-16. PubMed ID: 21947519 [TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological effects of Schistosoma mansoni infection associated with simultaneous exposure to malathion in Swiss outbred albino mice. Elsheikha HM; Hussein HS; Rahbar MH Acta Trop; 2008 Oct; 108(1):11-9. PubMed ID: 18722991 [TBL] [Abstract][Full Text] [Related]
8. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study. Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884 [TBL] [Abstract][Full Text] [Related]
9. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. El-Lakkany NM; Hammam OA; El-Maadawy WH; Badawy AA; Ain-Shoka AA; Ebeid FA Parasit Vectors; 2012 Jan; 5():9. PubMed ID: 22236605 [TBL] [Abstract][Full Text] [Related]
11. Antioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasis. Dkhil MA; Bauomy AA; Diab MS; Al-Quraishy S Int J Nanomedicine; 2015; 10():7467-75. PubMed ID: 26719689 [TBL] [Abstract][Full Text] [Related]
12. Improvement of the liver pathology by the aqueous extract and the n-butanol fraction of Sida pilosa Retz in Schistosoma mansoni-infected mice. Jatsa HB; Russo RC; Pereira CA; Aguilar EC; Garcia CC; Araújo ES; Oliveira JL; Rodrigues VF; de Oliveira VG; Alvarez-Leite JI; Braga FC; Louis-Albert Tchuem Tchuente ; Kamtchouing P; Negrão-Corrêa DA; Teixeira MM J Ethnopharmacol; 2016 Mar; 180():114-23. PubMed ID: 26806570 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of Schistosoma mansoni infection in outbred albino mice exposed to Larvin contaminant. Attallah AM; Wahba MA; Elsheikha HM; Abbas AT; Abdel Aziz MM; El-Hemaly MA Parasitol Res; 2008 Aug; 103(3):567-76. PubMed ID: 18512077 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis. Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036 [TBL] [Abstract][Full Text] [Related]